Universal CAR-T cells targeting BCMA and CD19
/ BRL Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 08, 2024
Universal CAR-T Cell Therapy for Refractory Lupus Nephritis
(clinicaltrials.gov)
- P1 | N=10 | Not yet recruiting | Sponsor: Bioray Laboratories
New P1 trial • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
1 to 1
Of
1
Go to page
1